Professur für Endokrinologie

Disease Control in Progressive Pancreatic and Intestinal Neuroendocrine Tumors by Combined Treatment with Lanreotide Autogel and Temozolomide: The SONNET Study (2018) Pavel ME, Denecke T, Lahner H, Hoersch D, Rinke A, Koch A, Liyanage N, et al. Conference contribution First Patient Survey about Tumor - Associated Fatigue in NEN (2018) Banz S, Mellar K, Letsch A, Scheibenbogen C, Pavel ME, Grabowski P Conference contribution The Effects of Different Isocaloric Oral Nutrient Solutions on Psychophysical, Metabolic, Cognitive, and Olfactory Function in Young Male Subjects (2017) Bachlechner S, Denzer-Lippmann MY, Wielopolski J, Fischer M, Büttner A, Dörfler A, Schöfl C, et al. Journal article The Effects of a Normal Rate versus a Slow Intervalled Rate of Oral Nutrient Intake and Intravenous Low Rate Macronutrient Application on Psychophysical Function - Two Pilot Studies (2017) Denzer-Lippmann M, Bachlechner S, Wielopolski J, Fischer M, Büttner A, Dörfler A, Schöfl C, et al. Journal article Extension study to the open-label, multi-center, expanded access study of everolimus in patients with advanced neuroendocrine tumors (2017) Doerffel Y, Kullmann F, Lammert F, Quietzsch D, Schöfl C, Schuppert F, Weber M, et al. Conference contribution Effects of different isocaloric oral nutrient solutions on olfactory functioning, hunger and food craving (2017) Thürauf N, Denzer-Lippmann M, Bachlechner S, Wielopolski J, Fischer M, Büttner A, Dörfler A, et al. Conference contribution Combined lanreotide autogel and temozolomide in progressive neuroendocrine tumours: an interim safety analysis of the SONNET study (2017) Hoersch D, Raderer M, Lahner H, Rinke A, Denecke T, Koch A, Raspel A, et al. Conference contribution Polycystic Ovary Syndrome (PCOS) in Juvenile and Adult Type 1 Diabetes in a German/Austrian Cohort (2017) Reinauer C, Bollow E, Froehlich-Reiterer E, Laubner K, Bergis D, Schöfl C, Kempe HP, et al. Journal article Health-related quality of life for everolimus versus placebo in patients with advanced, non-functional, well-differentiated gastrointestinal or lung neuroendocrine tumours (RADIANT-4): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial (2017) Pavel ME, Singh S, Strosberg JR, Bubuteishvili-Pacaud L, Degtyarev E, Neary MP, Carnaghi C, et al. Journal article Comparing the effects of isocaloric oral and i.v. application of nutrient solutions on olfactory functioning (2016) Bachlechner S, Denzer-Lippmann M, Wielopolski J, Fische M, Büttner A, Dörfler A, Schöfl C, et al. Conference contribution